Peregrine Pharmaceuticals Announces Partial Exercise of Overallotment Option in Connection With Preferred Stock Offering
[Marketwired] – Peregrine Pharmaceuticals, Inc. , announced today that the underwriters of its underwritten public offering of its 10.50% Series E Convertible Preferred Stock have partially exercised their option to cover … more
View todays social media effects on PPHM
View the latest stocks trending across Twitter. Click to view dashboard